KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesReal Estate - NetReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthpeak Properties (DOC) Liabilities from Discontinued Operations (2016 - 2022)

Healthpeak Properties (DOC) has disclosed Liabilities from Discontinued Operations for 12 consecutive years, with 11798000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 11798000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 11798000.0, a N/A change, with the full-year FY2025 number at 11798000.0, changed N/A from a year prior.
  • Liabilities from Discontinued Operations was 11798000.0 for Q4 2025 at Healthpeak Properties, down from 12831000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 65272000.0 in Q2 2021 to a low of 11798000.0 in Q4 2025.
  • A 3-year average of 24165200.0 and a median of 15056000.0 in 2021 define the central range for Liabilities from Discontinued Operations.
  • Biggest YoY gain for Liabilities from Discontinued Operations was 99.93% in 2021; the steepest drop was 96.38% in 2021.
  • Healthpeak Properties' Liabilities from Discontinued Operations stood at 15056000.0 in 2021, then dropped by 14.78% to 12831000.0 in 2022, then decreased by 8.05% to 11798000.0 in 2025.
  • Per Business Quant, the three most recent readings for DOC's Liabilities from Discontinued Operations are 11798000.0 (Q4 2025), 12831000.0 (Q3 2022), and 15869000.0 (Q2 2022).